CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market sale Director sold 44,472 shares at $50.35 ($2,239,076)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $48.58 ($437,220)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $48.58 ($98,812)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K/A Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $54.03 ($109,897)
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at an average $51.51 ($463,621)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale Director sold 2,000 shares at $45.10 ($90,200)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $43.05 ($87,564)
- 144 Insider Sale of Securities
Page 2 of 97 · 1,927 filings